Precision for Medicine

Precision for Medicine is a specialized, full-service CRO founded in 2012, headquartered in Bethesda, Maryland. It differentiates itself by combining deep expertise in oncology and rare diseases with integrated capabilities in translational science, biomarker development, global central lab services, and data intelligence. The company serves as a strategic partner for biopharma innovators, aiming to reduce development costs, increase the probability of regulatory approval, and accelerate time-to-market for complex therapies. Its recent recognition with a Fierce Biotech CRO Award underscores its focus on innovative solutions and operational rescue in high-risk trials.

Integrated ecosystem combining global central lab & specialty labs for translational/biomarker science, companion diagnostics (CDx) development, data intelligence (AI/ML analytics), and technology-enabled clinical trial operations.

Competes directly with large, full-service global CROs (e.g., IQVIA, Parexel, PPD) and large central lab companies (e.g., LabCorp, Q2 Solutions) that offer similar integrated suites. Differentiation is based on being 'right-sized,' with deeper therapeutic expertise in complex areas, more dedicated team resources, and a focus on integrated science over pure operational scale.